Illumina Unveils the MiSeq i100 Series: Revolutionizing Benchtop Sequencing
Wednesday, Oct 23, 2024 10:07 pm ET
1min read Illumina, a global leader in DNA sequencing and array-based technologies, has recently introduced the MiSeq i100 Series, marking a significant milestone in the field of next-generation sequencing (NGS). This new series of benchtop sequencers offers unparalleled speed, simplicity, and sustainability, empowering labs worldwide to unlock powerful insights and drive discovery.
The MiSeq i100 Series consists of two powerful, compact instruments: the MiSeq i100 and MiSeq i100 Plus Systems. These sequencers deliver results up to four times faster than their predecessors, with run times as fast as four hours. This remarkable speed enables same-day and even same-shift results, revolutionizing the way researchers approach sequencing projects.
One of the key technologies behind the MiSeq i100 Series' simplicity and speed is Illumina's XLEAP-SBS chemistry. This innovative chemistry eliminates the need for thawing requirements, allowing reagents to be used whenever a sample is ready. This flexibility enables labs to sequence on demand, without the need for specialized storage facilities or equipment.
The MiSeq i100 Series also introduces streamlined workflows and push-button operations, making it easier than ever for researchers with varying levels of sequencing experience to obtain high-quality data. The instruments offer 18 proven end-to-end workflows across 10 applications, providing metrics either directly on the instrument or via cloud-based DRAGEN genomic data analysis. This user-friendly approach minimizes the need for bioinformatics expertise and enables researchers to focus on their core scientific questions.
In addition to its simplicity and speed, the MiSeq i100 Series is designed with sustainability in mind. The instruments feature an 85% reduction in packaging waste compared to previous MiSeq systems, as well as the use of recyclable plastics. Room-temperature shipping and storage further enhance the sustainability of the MiSeq i100 Series, reducing the environmental impact of sequencing projects.
The MiSeq i100 Series' room-temperature storage and shipping capabilities also contribute to its usability and efficiency. By eliminating the need for specialized storage facilities and equipment, smaller labs and research institutions can now access the benefits of NGS without significant upfront investments. Furthermore, the elimination of thawing requirements for reagents enables more flexible and on-demand sequencing, improving accessibility for urgent samples and time-sensitive research.
In conclusion, Illumina's MiSeq i100 Series represents a significant advancement in benchtop sequencing. With its unparalleled speed, simplicity, and sustainability, the MiSeq i100 Series empowers labs worldwide to unlock powerful insights and drive discovery. As the demand for NGS continues to grow, the MiSeq i100 Series is poised to become an essential tool for researchers seeking to push the boundaries of scientific understanding.
The MiSeq i100 Series consists of two powerful, compact instruments: the MiSeq i100 and MiSeq i100 Plus Systems. These sequencers deliver results up to four times faster than their predecessors, with run times as fast as four hours. This remarkable speed enables same-day and even same-shift results, revolutionizing the way researchers approach sequencing projects.
One of the key technologies behind the MiSeq i100 Series' simplicity and speed is Illumina's XLEAP-SBS chemistry. This innovative chemistry eliminates the need for thawing requirements, allowing reagents to be used whenever a sample is ready. This flexibility enables labs to sequence on demand, without the need for specialized storage facilities or equipment.
The MiSeq i100 Series also introduces streamlined workflows and push-button operations, making it easier than ever for researchers with varying levels of sequencing experience to obtain high-quality data. The instruments offer 18 proven end-to-end workflows across 10 applications, providing metrics either directly on the instrument or via cloud-based DRAGEN genomic data analysis. This user-friendly approach minimizes the need for bioinformatics expertise and enables researchers to focus on their core scientific questions.
In addition to its simplicity and speed, the MiSeq i100 Series is designed with sustainability in mind. The instruments feature an 85% reduction in packaging waste compared to previous MiSeq systems, as well as the use of recyclable plastics. Room-temperature shipping and storage further enhance the sustainability of the MiSeq i100 Series, reducing the environmental impact of sequencing projects.
The MiSeq i100 Series' room-temperature storage and shipping capabilities also contribute to its usability and efficiency. By eliminating the need for specialized storage facilities and equipment, smaller labs and research institutions can now access the benefits of NGS without significant upfront investments. Furthermore, the elimination of thawing requirements for reagents enables more flexible and on-demand sequencing, improving accessibility for urgent samples and time-sensitive research.
In conclusion, Illumina's MiSeq i100 Series represents a significant advancement in benchtop sequencing. With its unparalleled speed, simplicity, and sustainability, the MiSeq i100 Series empowers labs worldwide to unlock powerful insights and drive discovery. As the demand for NGS continues to grow, the MiSeq i100 Series is poised to become an essential tool for researchers seeking to push the boundaries of scientific understanding.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
